THE PATHOGENESIS OF URINARY DISORDERS AND ERECTION IN PATIENTS WITH CEREBROVASCULAR DISEASES
https://doi.org/10.21886/2308-6424-2016-0-1-52-71
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
The paper describes the main pathogenetic mechanisms of forming persistent neurogenic voiding and sexual function in patients with acute and chronic cerebrovascular disease. Neuroanatomy and neurophysiology described urination and sexual function in normal and vascular disease of the brain. Possibilities different centers urination brain to reorganize functions by associative or contralateral areas of innervation. The role of lower urinary tract symptoms and sexual disorders in the diagnosis level and nature of damage to the central nervous system. Revealed the most important clinical and pathogenetic correlation between urinary and reproductive disorders, the most common in acute and chronic ischemia centers urination and sexual function. The possible common ways of pharmacological correction of functional disorders.
About the Authors
P. G. Shvarts
Research Center of Neurology
Russian Federation
Moscow
Russian Federation
Moscow
V. V. Dutov
Moscow Regional Research and Clinical Institute
Russian Federation
Moscow
Russian Federation
Moscow
A. S. Kadykov
Research Center of Neurology
Russian Federation
Moscow
Russian Federation
Moscow
S. V. Sheldeshev
City polyclinic №195
Russian Federation
Moscow
Russian Federation
Moscow
A. V. Bershadsky
Central City Hospital №3
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
References
1. Shvarts P.G. Fenomenologiya neirogennykh narushenii mocheispuskaniya. //Rus med zhurn. - 2012. - № 18. - S. 912-916.
2. Popov S.V. Erektil'naya disfunktsiya pri zabolevaniyakh tsentral'noi nervnoi sistemy //Farmateka.- 2014. - №19. - S.74-75.
3. Pushkar' D.Yu. Erektil'naya disfunktsiya: kardiologicheskie aspekty. /Pushkar' D.Yu., Vertkin A.L. - M.: MEDpress-inform, 2005. - 144 s.
4. Shvarts P.G. Patogeneticheskie mekhanizmy narushenii mocheispuskaniya i erektsii u patsientov s sosudistymi zabolevaniyami golovnogo mozga i ikh farmakologicheskaya korrektsiya. //RMZh.- 2015. - № 11.- S. 639-646.
5. Shvarts P.G. Neirogennye narusheniya mocheispuskaniya u bol'nykh s ostrymi i khronicheskimi sosudistymi zabolevaniyami golovnogo mozga (klinika, diagnostika i lechenie). Diss. … dokt. med. Nauk. - M., 2013. - 285 s.
6. Sakakibara R. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. /Sakakibara R., Hattori T., Uchiyama T., et al. // J. Neurol. Neurosurg. Psychiatry- 1999. - Vol.67 - P. 658-660.
7. Thompson I.M. et al., Erectile dysfunction and subsequent cardiovascular disease. //JAMA. - Dec. 21. - 2005. - 294. -R. 2996-3002.
8. Aytac I.A. Socioeconomic factors and incidence of erectile dysfunction: findings of the longitudinal Massachusetts Male Aging Study. /Aytac I.A., Araujo A.B., Johannes C.B., et al //SocSciMed. - 2000. - No.51. - R. 771-778.
9. Billups K.L. Erectile dysfunction as an early indicator of systemic oxidative stress and endothelial cell dysfunction. /Billups K.L., Edina M.N., Kaiser D. et al. //J. Urol. - 2003; - №169. - R. 323-327.
10. Shvarts P.G. Neirogennaya zaderzhka mochi. / Shvarts P.G., Popov S.V. - M: -Press Byuro- 2011. -224 c.
11. Truss M.C. Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside. / Truss M.C., Stief C.G., et al. //World J Urol-2001-19: - R. 344-350.
12. Uckert S. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate./ Uckert S., Kuthe A., Jonas U. and Stief C.G. // J Urol- 2001 -166: - R.2484-90.
13. Andersson K.E. LUTS treatment: future treatment options. //Neurourol Urodyn - 2007, vol. 26 - R. 934-47.
14. Tazhetdinov O.Kh. Effektivnost' i bezopasnost' ingibitorov fosfodiesterazy 5-go tipa u muzhchin s erektil'noi disfunktsiei i simptomami nizhnikh mochevykh putei. / Tazhetdinov O.Kh., Tkhagapsoeva R.A., Pavlovichev A.A. //Farmateka. - 2011. - №20. - S. 22-29.
15. Sairam K. Sildenafil influences lower urinary tract symptoms. / Sairam K., Kulinskaya E., et al. //BJU Int-2002 -90: - R. 836-9.
16. Guilleminault Ch. Clinical Neurophysiology of Sleep Disorders. - Elsevier Health Sciences. - 2005. - 363 p.
17. Giembycz M.A. Life after PDE4: overcoming adverse events with dualspecificity phosphodiesterase inhibitors. // CurrOpinPharmacol. - 2005- vol 5: - R. 238-44.
18. Gillespie J.L. Phosphodiesterase-linked inhibition of nonmicturition activity in the isolated bladder. // BJU Int -2004 -93: - R.1325-32.
Review
For citations:
Shvarts P.G., Dutov V.V., Kadykov A.S., Sheldeshev S.V., Bershadsky A.V. THE PATHOGENESIS OF URINARY DISORDERS AND ERECTION IN PATIENTS WITH CEREBROVASCULAR DISEASES. Urology Herald. 2016;(1):52-71. (In Russ.) https://doi.org/10.21886/2308-6424-2016-0-1-52-71
Views:
1584
ISSN 2308-6424 (Online)
Email this article 
